The Venture Codex Logo

The Venture Codex

Enavate Sciences

106 W 56th St 8th Floor, New York, NY, 10019, United States

Overview

Investing in and supporting innovative therapeutic technology companies.

Founded

2019

Deals ยท 12mo

2

Links

WebsiteLinkedIn

Stage focus

Series A
Series B
Series C

Geographic focus

United States

Sector focus

Health Care
Life Science
Medical

Investment portfolio

14rounds
NAMEDATESIZE
AirNexis Therapeutics
Jan 2026Participated
$200 MSeries A
Braveheart Bio
Nov 2025Participated
$185 MSeries A
Normunity
Jan 2025Led
$75 MSeries B
Aviceda Therapeutics
Jan 2025Participated
$208 MSeries C
OrsoBio
Sep 2024Participated
$67 MSeries B
Zenas BioPharma
May 2024Participated
$200 MSeries C
BridgeBio Oncology Therapeutics
May 2024Participated
$200 MOther Equity
Sionna Therapeutics
Mar 2024Led
$182 MSeries C
OrsoBio
Nov 2023Led
$60 MSeries A
Upstream Bio
Jun 2023Led
$200 MSeries B
Zenas BioPharma
Nov 2022Led
$118 MSeries B
Camp4
Jul 2022Led
$100 MSeries B
AirNexis Therapeutics
Jan 2026Participated
$200 MSeries A
Braveheart Bio
Nov 2025Participated
$185 MSeries A
Normunity
Jan 2025Led
$75 MSeries B
Aviceda Therapeutics
Jan 2025Participated
$208 MSeries C
OrsoBio
Sep 2024Participated
$67 MSeries B
Zenas BioPharma
May 2024Participated
$200 MSeries C
BridgeBio Oncology Therapeutics
May 2024Participated
$200 MOther Equity
Sionna Therapeutics
Mar 2024Led
$182 MSeries C
OrsoBio
Nov 2023Led
$60 MSeries A
Upstream Bio
Jun 2023Led
$200 MSeries B
Zenas BioPharma
Nov 2022Led
$118 MSeries B
Camp4
Jul 2022Led
$100 MSeries B
14
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Enavate Sciences: 14 funding rounds are recorded in the selected participation categories.All available history.
Enavate Sciences: 14 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A12
Series B51
Series C+12
Other Equity11

Monthly Deal Activity

Enavate Sciences: 14 deals are recorded across 53 months.All available history.
Enavate Sciences: 14 deals are recorded across 53 months. All available history
MonthDeals
Jun '221
Jul '222
Aug '220
Sep '220
Oct '220
Nov '221
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '231
Jul '230
Aug '230
Sep '230
Oct '230
Nov '231
Dec '230
Jan '240
Feb '240
Mar '241
Apr '240
May '242
Jun '240
Jul '240
Aug '240
Sep '241
Oct '240
Nov '240
Dec '240
Jan '252
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '251
Dec '250
Jan '261
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Enavate Sciences: Health & Life Sciences is the largest displayed sector by deal count (13 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Enavate Sciences: Health & Life Sciences is the largest displayed sector by deal count (13 deals). All available history
SectorDeals
Health & Life Sciences13
Education & Workforce1
Professional Services1

Deal Size Distribution

Enavate Sciences: 14 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Enavate Sciences: 14 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M0
$25M-$50M0
$50M-$100M3
$100M-$250M11
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Enavate Sciences: United States has the largest recorded deal count among the displayed regions (14 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Enavate Sciences: United States has the largest recorded deal count among the displayed regions (14 deals). All available history
RegionDeals
United States14
Enavate Sciences: 20 co-investors are shown, with Longitude Capital sharing 6 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Enavate Sciences: 20 co-investors are shown, with Longitude Capital sharing 6 recorded deals. All available history
Co-investorShared deals
Longitude Capital6
OrbiMed5
Samsara BioCapital4
Wellington Management4
Andreessen Horowitz3
Omega Funds3
5AM Ventures2
Eli Lilly and Company2
Fairmount2
Frazier Life Sciences2
Gaingels2
Northpond Ventures2
NuevaBio2
Perceptive Advisors2
Pivotal bioVenture Partners2
Polaris Partners2
Rock Springs Capital2
SR One2
Superstring Capital2
TCGX2

Investment Strategy

Enavate Sciences: Led accounts for 57% and participating for 43% of round participation.All available history.
Enavate Sciences: Led accounts for 57% and participating for 43% of round participation. All available history
CategoryDeals (count)Share (%)
Led857%
Participating643%
Enavate Sciences: Single-lead accounts for 63% and co-led for 38% of lead dynamics.All available history.
Enavate Sciences: Single-lead accounts for 63% and co-led for 38% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead563%
Co-led338%

Team

Christine Del Corsano

Chief Financial Officer

Edd Fleming

Executive Vice President, Commercialization

James Boylan

Chief Executive Officer

Robert Glassman

EVP, Search and Evaluation